Evidence map›Paper›PMID 41347516›Full record

ArticleThe Journal of laryngology and otology2026

The incidence of avid lesions in head and neck cancer patients undergoing positron emission tomography-computed tomography scanning.

Abbie Carter, Huw Rhys Davies, Ali A Salamat, Neela Mouli Doddi

Abstract read
In one paragraph

Article in The Journal of laryngology and otology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abbie CarterCardiff University School of Medicine, Wales, UK.ORCID https://orcid.org/0000-0002-9008-2841
Huw Rhys DaviesENT Department, Royal Glamorgan Hospital, Llantrisant, Wales, UK.
Ali A SalamatENT Department, Royal Glamorgan Hospital, Llantrisant, Wales, UK.
Neela Mouli DoddiENT Department, Royal Glamorgan Hospital, Llantrisant, Wales, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to determine the incidence, location and outcome of incidental avid lesions on positron emission tomography-computed tomography scans for head and neck cancer.

methodsA retrospective study reviewing digital case notes, performed from a single centre. Clinicopathological information was collected and incidental avid lesions on positron emission tomography-computed tomography reports were recorded. Further investigations were followed up to determine the outcome of the lesions.

resultsA total of 281 patients undergoing staging positron emission tomography-computed tomography (stages T4, N3 or unknown primary) and/or treatment response positron emission tomography-computed tomography scans for head and neck cancer were identified, with 363 incidental avid lesions reported in 369 scans. The most common location was the abdomen (30.0 per cent), followed by thorax (28.9 per cent). A total of 33.1 per cent of lesions had further investigation. The rate of incidental synchronous primary was 3.6 per cent.

conclusionThe benefit of investigating carefully selected incidental avid lesions outweighs the harm of investigation, as it may alter management. There is a need for a standardised pathway for investigating these lesions in head and neck cancer services.

Indexed as

Head and Neck NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overFemaleHumansIncidenceIncidental FindingsMaleMiddle AgedNeoplasms, Multiple PrimaryNeoplasm StagingRetrospective Studiescarcinomahead and neck neoplasmsneoplasmspositron emission tomography-computed tomographyretrospective studiessquamous cellunknown primary

Identifiers

PMID41347516
PMCPMC13121044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.